Paper42928985PubMed
Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI-CKD.
Xi L and 4 others. Cell Biochem Funct, 2026.
Cite this record
ConductScience Library. Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI-CKD. Papers, record 42928985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42928985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI-CKD.
- Journal
- Cell Biochem Funct
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| NF-E2-Related Factor 2 | Major topic |
| Signal Transduction | Major topic |
| Heme Oxygenase-1 | Major topic |
| Deoxyadenosines | Major topic |
| Acute Kidney Injury | Major topic |
| Membrane Proteins | Major topic |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Humans | |
| Male | |
| Molecular Docking Simulation | |
| Cell Line |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| YDZJSX2025B007 | Local Science and Technology Development Funds Projects Guided by Central Government | PubMed | ||
| 82300846 | National Natural Science Foundation of China | PubMed | ||
| 202303021212347 | Fundamental Research Program of Shanxi Province | PubMed | ||
| 2024-151 | Shanxi Scholarship Council of China | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37107307 | Nrf2 Protein Serum Concentration in Human CKD Shows a Biphasic Behavior. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107307 | PubMed |
| 2 | 31951250 | Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stress. | Acta Biochim Biophys Sin (Shanghai) | 2020 | https://conductscience.org/library/papers/31951250 | PubMed |
| 3 | 33348963 | Protective effect of cordycepin on experimental renal ischemia/reperfusion injury in rats. | Arch Ital Urol Androl | 2020 | https://conductscience.org/library/papers/33348963 | PubMed |
| 4 | 35140713 | Sympathetic Denervation Ameliorates Renal Fibrosis via Inhibition of Cellular Senescence. | Front Immunol | 2021 | https://conductscience.org/library/papers/35140713 | PubMed |
| 5 | 41575219 | Cordycepin Suppressed Ferroptosis to Ameliorate Acute Kidney Injury Through Inhibiting the DNMT1/KLF15/FTH1 Axis. | FASEB J | 2026 | https://conductscience.org/library/papers/41575219 | PubMed |
| 6 | 41162865 | CircAASS alleviates renal injury and fibrosis by regulating mitochondrial homeostasis in tubular epithelial cells. | Autophagy | 2026 | https://conductscience.org/library/papers/41162865 | PubMed |
| 7 | 37890360 | HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression. | Redox Biol | 2023 | https://conductscience.org/library/papers/37890360 | PubMed |
| 8 | 37329950 | Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies. | Transl Res | 2023 | https://conductscience.org/library/papers/37329950 | PubMed |
| 9 | 39954658 | Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway. | Int Immunopharmacol | 2025 | https://conductscience.org/library/papers/39954658 | PubMed |
| 10 | 41139039 | Shen-Shuai-II-Recipe suppresses hypoxia-induced oxidative stress and ferroptosis via Nrf2 activation to ameliorate renal fibrosis in chronic kidney disease. | J Ethnopharmacol | 2026 | https://conductscience.org/library/papers/41139039 | PubMed |
| 11 | 41559050 | TET1 as a master regulator controlling GPX4-dependent and -independent ferroptosis surveillance in acute myeloid leukemia. | Nat Commun | 2026 | https://conductscience.org/library/papers/41559050 | PubMed |
| 12 | 40373638 | Cordycepin ameliorates high glucose-induced proliferation, inflammation, and extracellular matrix deposition in glomerular mesangial cells through Smad7-dependent manner. | Mol Immunol | 2025 | https://conductscience.org/library/papers/40373638 | PubMed |
| 13 | 42928985 | Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI-CKD. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42928985 | PubMed |
| 14 | 35058924 | Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation. | Front Immunol | 2021 | https://conductscience.org/library/papers/35058924 | PubMed |
| 15 | 38014886 | Cordycepin inhibits kidney injury by regulating GSK-3β-mediated Nrf2 activation. | J Biochem Mol Toxicol | 2024 | https://conductscience.org/library/papers/38014886 | PubMed |
| 16 | 39748508 | ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD. | Mol Ther | 2025 | https://conductscience.org/library/papers/39748508 | PubMed |
| 17 | 31506103 | Xanthohumol inhibits PRRSV proliferation and alleviates oxidative stress induced by PRRSV via the Nrf2-HMOX1 axis. | Vet Res | 2019 | https://conductscience.org/library/papers/31506103 | PubMed |
| 18 | 39845897 | Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39845897 | PubMed |
| 19 | 39093381 | Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39093381 | PubMed |
| 20 | 31366430 | The Incidence of Acute Kidney Injury and Associated Hospital Mortality. | Dtsch Arztebl Int | 2019 | https://conductscience.org/library/papers/31366430 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42928985 | Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI-CKD. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42928985 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42928985
GET https://conductscience.org/api/papers/v1/42928985/references?page=2